ADORA2A and neoplasm: Importantly, A2AR inhibition was found to exhibit the most pronounced effects during CD8+ effector T cell activation, thus remarkably reducing PD-1 and LAG-3 expression at the draining lymph nodes of tumor bearing mice [109].